by admin | Oct 8, 2019 | Clinical Trials
The narcolepsy drug, developed by Irish company Jazz Pharmaceuticals, has a lower salt content than the current treatment Xyrem, making it more suitable for patients at risk of cardiovascular disease. In a 200-patient phase III trial that finished in July, Jazz...
by admin | Oct 8, 2019 | M&A - Buy-Out
US medical device company AngioDynamics Inc. (NASDAQ: ANGO) announced an agreement to acquire Israel laser technology developer Eximo Medical Ltd. for $46 million and up to $20 million in milestone payments. Based in Rehovot, Eximo Medical is an early commercial...
by admin | Sep 27, 2019 | Funding
The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an environmentally friendly crop pesticide inspired by llama antibodies. AgroSavfe will use the funds to develop and manufacture its lead protein fungicide on a commercial scale. The...
